T cell response to alpha crystallin and Mycobacterium tuberculosis specific antigens using ex-vivo ELISPOT assay for detecting latent tuberculosis infection in Addis Ababa, Ethiopia

Ethiopian Medical Journal

Volumn , Issue SUPPL. 1, 2014, Pages 15-22

  Mamo, Gezahegne ^a,b,c   Mihret, Adane ^a,b   Taffesse, Mesfin ^b   Gebru, Girmai ^c   Afework, Mekbeb ^c   Yamuah, Lawerence K ^b   Wassie, Liya ^b   Abebe, Markos ^b   Aseffa, Abraham ^b   Parida, Shreemantha K ^b,d  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; BIOLOGICAL MARKER; CFP 10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; CFP-10 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT 6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS; ESAT-6 PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; ETHIOPIA; FEMALE; HUMAN; IMMUNOLOGY; LATENT TUBERCULOSIS; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE;

ADOLESCENT; ADULT; ALPHA-CRYSTALLINS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; ETHIOPIA; FEMALE; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES;

EID: 84898853425     PISSN: 00141755     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Hernandez-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, Rook GA, Bjune G. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet 2000;356:2133-2138.
2. Wayne L G. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994; 13:908-914.
3. O'Toole R, Smeulders M J, Blokpoel MC, Kay E J, Lougheed K, Williams HD. A two-component regulator ef universal stress protein expression and adaptation to oxygen starvation in Mycobacterium smegmatis. J Bacteriol 2003;185:1543-1554. (Pubitemid 36245956)
4. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell Ml, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha-crystallin. Proc Natl Acad Sci USA 2001; 98:7534-7539. (Pubitemid 32567983)
5. YuanY, Crane DD, Barry III C E. Stationary phase-associated protein expression in Mycobacterium tubercu-losis: function of the mycobacterial alpha-crystallin homolog. J Bacteriol 1996; 178:4484-492. (Pubitemid 26262233)
6. Cunningham AF and Spreadbury CL. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 1998; 180: 801-08. (Pubitemid 28084203)
7. Lim A, Eleuterio M, Hutter B, Murugasu-Oei B, Dick T. Oxygen depletion-induced dormancy in Mycobacte-rium bovis BCG. J Bacteriol 1999;181:2252-2256. (Pubitemid 29164981)
8. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ. Expression of Th1-mediated immunity in mouse lungs in-duces a Mycobacterium tuberculosis transcription pattern characteristic of non-replicating persistence. Proc Natl Acad Sci USA 2003;100:241-246. (Pubitemid 36078059)
9. Doherty, T. M., A. Demissie, D. Menzies, P. Andersen, G. Rook, and A.Zumla. Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, EL1SPOT and quantitative PCR. J Immunol Methods 2005; 298:129-41. (Pubitemid 40545099)
10. Laivani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD8+ memory T cells. J Exp Med 1997; 186:859-65. (Pubitemid 27407347)
11. Menzies R and Vissandjee B. Effect of bacille Calmette-Guerin vaccination on tuberculin reactivity. Am. Rev. Respir. Dis 1992; 145:621-25.
12. Wang J, Zganiacz A, Xing Z. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 2002; 20:2887-2898. (Pubitemid 34785958)
13. Anderson R P, Degano P, Godkin AJ, Jewell DP, Hill AV. In vivo antigen challenge in celiac disease identi-fies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope. Nat Med 2000; 6:337-342. (Pubitemid 30148628)
14. Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, Donkor SA, Hammond AS, Corrah T, Adegbola RA, McAdam KP, Brookes RH. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis 2005; 40:273-278 (Pubitemid 40110673)
15. Kimman TG, Vandebriel RJ, Hoebee B: Genetic variation in the response to vaccination. Community Genet 2007, 10(4):201-217. (Pubitemid 47482080)
16. McNamara, LA, He, Y. and Yang, Z. Using epitope predictions to evaluate efficacy and population coverage of the Mtb72f vaccine for tuberculosis BMC Immunology 2010, 11:18.
17. Vekemans J, Ota MO, Sillah J, Fielding K, Alderson MR, Skeiky YA, Dalemans W, McAdam KP, Lienhardt C, Marchant A. Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design. Infect Immun 2004; 72:381-8. (Pubitemid 38018199)
18. Wilkinson RJ, Wilkinson KA, De Smet KA, Haslov K, Pasvol G, Singh M, Svarcova 1, lvanyi J. Human Tand B-cell reactivity to the 16kDa alpha-crystallin protein of Mycobacterium tuberculosis. Scand J Immunol 1998;48:403-9. (Pubitemid 28459658)